Mwg Management Ltd. Lyell Immunopharma, Inc. Transaction History
Mwg Management Ltd.
- $58.7 Million
- Q1 2025
A detailed history of Mwg Management Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mwg Management Ltd. holds 20,162,332 shares of LYEL stock, worth $8.87 Million. This represents 18.54% of its overall portfolio holdings.
Number of Shares
20,162,332
Previous 20,162,332
-0.0%
Holding current value
$8.87 Million
Previous $12.9 Million
15.62%
% of portfolio
18.54%
Previous 17.35%
Shares
3 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$7.04 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.64 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.64 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.94 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$5.24 Million1.8% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $109M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...